BD Begins Clinical Trial for GalaFLEX LITE Scaffold in Breast Revision Surgery
BD begins a clinical trial to evaluate GalaFLEX LITE Scaffold for reducing capsular contracture in breast revision surgery, aiming for FDA approval.
BD begins a clinical trial to evaluate GalaFLEX LITE Scaffold for reducing capsular contracture in breast revision surgery, aiming for FDA approval.
The treatment is the first short-duration facial injectable available in the region for the temporary improvement of lines between the eyebrows.